An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults

Vaccine

Volumn 29, Issue 17, 2011, Pages 3144-3148

  Talaat, Kawsar R ^a   Karron, Ruth A ^a   Luke, Catherine J ^b   Thumar, Bhagvanji ^a   McMahon, Bridget A ^a   Chen, Grace L ^b   Lamirande, Elaine W ^b   Jin, Hong ^c   Coelingh, Kathy L ^c   Kemble, George ^c   Subbarao, Kanta ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c MEDIMMUNE   (United States)

Author keywords

Avian influenza; H6N1; Live attenuated; Vaccine

Indexed keywords

H6N1 TEAL HK97/AA CA VACCINE; HEMAGGLUTININ; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFLUENZA VACCINE; LIVE VACCINE; SIALIDASE; UNCLASSIFIED DRUG;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADULT; ANTIBODY RESPONSE; ARTICLE; COUGHING; DIZZINESS; DRUG SAFETY; FATIGUE; FEMALE; HEADACHE; HUMAN; HUMAN EXPERIMENT; IMMUNOGENICITY; INFLUENZA A; INFLUENZA VIRUS A; INFLUENZA VIRUS A H6N1; LYMPHADENOPATHY; MALAISE; MALE; MYALGIA; NECK PAIN; NORMAL HUMAN; NOSE CONGESTION; OPEN STUDY; PERIPHERAL BLOOD MONONUCLEAR CELL; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RHINORRHEA; SORE THROAT; VIRUS REPLICATION; WHEEZING;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; ENZYME-LINKED IMMUNOSPOT ASSAY; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFLUENZA VACCINES; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NEUTRALIZATION TESTS; ORTHOMYXOVIRIDAE; VACCINATION; VACCINES, ATTENUATED; YOUNG ADULT;

EID: 79954611107     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.02.043     Document Type: Article

References (32)

1. Cheung C.L., Vijaykrishna D., Smith G.J., Fan X.H., Zhang J.X., Bahl J., et al. Establishment of influenza A virus (H6N1) in minor poultry species in southern China. J Virol 2007, 81(October (19)):10402-10412.
2. Chin P.S., Hoffmann E., Webby R., Webster R.G., Guan Y., Peiris M., et al. Molecular evolution of H6 influenza viruses from poultry in Southeastern China: prevalence of H6N1 influenza viruses possessing seven A/Hong Kong/156/97 (H5N1)-like genes in poultry. J Virol 2002, 76(January (2)):507-516.
3. Munster V.J., Baas C., Lexmond P., Waldenstrom J., Wallensten A., Fransson T., et al. Spatial, temporal, and species variation in prevalence of influenza A viruses in wild migratory birds. PLoS Pathog 2007, 3(May (5)):e61.
4. Shortridge K.F. Pandemic influenza: a zoonosis?. Semin Respir Infect 1992, 7(March (1)):11-25.
5. Woolcock P.R., Suarez D.L., Kuney D. Low-pathogenicity avian influenza virus (H6N2) in chickens in California, 2000-02. Avian Dis 2003, 47(3 Suppl):872-881.
6. Abolnik C., Bisschop S., Gerdes T., Olivier A., Horner R. Outbreaks of avian influenza H6N2 viruses in chickens arose by a reassortment of H6N8 and H9N2 ostrich viruses. Virus Genes 2007, 34(January (1)):37-45.
7. Claas E.C., Osterhaus A.D., van Beek R., De Jong J.C., Rimmelzwaan G.F., Senne D.A., et al. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 1998, 351(February (9101)):472-477.
8. Osterhaus A.D., de Jong J.C., Rimmelzwaan G.F., Claas E.C. H5N1 influenza in Hong Kong: virus characterizations. Vaccine 2002, 20(May (Suppl 2)):S82-S83.
9. Hoffmann E., Stech J., Leneva I., Krauss S., Scholtissek C., Chin P.S., et al. Characterization of the influenza A virus gene pool in avian species in southern China: was H6N1 a derivative or a precursor of H5N1?. J Virol 2000, 74(July (14)):6309-6315.
10. Butt K.M., Smith G.J., Chen H., Zhang L.J., Leung Y.H., Xu K.M., et al. Human infection with an avian H9N2 influenza A virus in Hong Kong in, 2003. J Clin Microbiol 2005, 43(November (11)):5760-5767.
11. Peiris M., Yuen K.Y., Leung C.W., Chan K.H., Ip P.L., Lai R.W., et al. Human infection with influenza H9N2. Lancet 1999, 354(September (9182)):916-917.
12. Abdel-Ghafar A.N., Chotpitayasunondh T., Gao Z., Hayden F.G., Nguyen D.H., de Jong M.D., et al. Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med 2008, 358(January (3)):261-273.
13. Gambotto A., Barratt-Boyes S.M., de Jong M.D., Neumann G., Kawaoka Y. Human infection with highly pathogenic H5N1 influenza virus. Lancet 2008, 371(April (9622)):1464-1475.
14. Munster V.J., Schrauwen E.J., de Wit E., van den Brand J.M., Bestebroer T.M., Herfst S., et al. Insertion of a multi basic cleavage motif into the hemagglutinin of a low pathogenic avian influenza H6N1 virus induces a highly pathogenic phenotype. J Virol 2010, 84(August (16)):7953-7960.
15. Myers K.P., Setterquist S.F., Capuano A.W., Gray G.C. Infection due to 3 avian influenza subtypes in United States veterinarians. Clin Infect Dis 2007, 45(July (1)):4-9.
16. Beare A.S., Webster R.G. Replication of avian influenza viruses in humans. Arch Virol 1991, 119(1-2):37-42.
17. Luke C.J., Subbarao K. Vaccines for pandemic influenza. Emerg Infect Dis 2006, 12(January (1)):66-72.
18. Subbarao K., Joseph T. Scientific barriers to developing vaccines against avian influenza viruses. Nat Rev Immunol 2007, 7(April (4)):267-278.
19. Karron R.A., Callahan K., Luke C., Thumar B., McAuliffe J., Schappell E., et al. A live attenuated H9N2 influenza vaccine is well tolerated and immunogenic in healthy adults. J Infect Dis 2009, 199(March (5)):711-716.
20. Karron R.A., Talaat K., Luke C., Callahan K., Thumar B., Dilorenzo S., et al. Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults. Vaccine 2009, 27(August (36)):4953-4960.
21. Talaat K.R., Karron R.A., Callahan K.A., Luke C.J., DiLorenzo S.C., Chen G.L., et al. A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults. Vaccine 2009, 27(June (28)):3744-3753.
22. WHO. Tables on the clinical trials of pandemic influenza prototype vaccines. 2009 8/25/2009 [cited 2/23/2010]. Available from: http://www.who.int/vaccine_research/diseases/influenza/flu_trials_tables/en/index.html.
23. Chen Z., Santos C., Aspelund A., Gillim-Ross L., Jin H., Kemble G., et al. Evaluation of live attenuated influenza a virus h6 vaccines in mice and ferrets. J Virol 2009, 83(January (1)):65-72.
24. Murphy B.R., Tierney E.L., Barbour B.A., Yolken R.H., Alling D.W., Holley H.P., et al. Use of the enzyme-linked immunosorbent assay to detect serum antibody responses of volunteers who received attenuated influenza A virus vaccines. Infect Immun 1980, 29(August (2)):342-347.
25. Rowe T., Abernathy R.A., Hu-Primmer J., Thompson W.W., Lu X., Lim W., et al. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol 1999, 37(April (4)):937-943.
26. Clements M.L., Donnel O., Levine S., Chanock M.M., Murphy R.M.B.R. Dose response of A/Alaska/6/77 (H3N2) cold adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus. Infect Immun 1983, 40:1044.
27. Sasaki S., Jaimes M.C., Holmes T.H., Dekker C.L., Mahmood K., Kemble G.W., et al. Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines. J Virol 2007, 81(January (1)):215-228.
28. Lai K.K., Cook L., Wendt S., Corey L., Jerome K.R. Evaluation of real-time PCR versus PCR with liquid-phase hybridization for detection of enterovirus RNA in cerebrospinal fluid. J Clin Microbiol 2003, 41(July (7)):3133-3141.
29. Gray G.C., McCarthy T., Capuano A.W., Setterquist S.F., Alavanja M.C., Lynch C.F. Evidence for avian influenza A infections among Iowa's agricultural workers. Influenza Other Respi Viruses 2008, 2(March (2)):61-69.
30. Samdal H.H., Bakke H., Oftung F., Holst J., Haugen I.L., Korsvold G.E., et al. A non-living nasal influenza vaccine can induce major humoral and cellular immune responses in humans without the need for adjuvants. Hum Vaccin 2005, 1(March-April (2)):85-90.
31. Halperin S.A., Smith B., Clarke K., Treanor J., Mabrouk T., Germain M., et al. randomized, controlled trial to study the reactogenicity and immunogenicity of a nasal, inactivated trivalent influenza virus vaccine in healthy adults. Hum Vaccin 2005, 1(January-February (1)):37-42.
32. Chen Z., Wang W., Zhou H., Suguitan A.L., Shambaugh C., Kim L., et al. Generation of live attenuated novel influenza virus A/California/7/09 (H1N1) vaccines with high yield in embryonated chicken eggs. J Virol 2010, 84(January (1)):44-51.